PlainPharmaWatch

CMS Open Payments · Program Year 2024

Orchard Therapeutics North America

Orchard Therapeutics North America reported $2,243,214.01 in payments to 69 physicians and teaching hospitals across 77 transactions.

See the rankings → How this is sourced
$2.2M
Total payments
77
Transactions
69
Recipients
#425
of 1,925 companies

Orchard Therapeutics North America reported $2,243,214.01 in payments to 69 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #425 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $32.5K per recipient across 3 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Orchard Therapeutics North America pairs top-quartile payment volume with a moderately concentrated payment pattern.

#425
of 1,925 companies
0.0%
of all US industry payments
0.3%
paid to its single top recipient
3
payment categories

How Orchard Therapeutics North America ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Orchard Therapeutics North America's total vs. every reporting company

CMS Open Payments, Program Year 2024

$2,243,214 Top 22% higher than 78% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Orchard Therapeutics North America

Rank #425 of 1,925 companies in CMS Open Payments for 2024 belongs to Orchard Therapeutics North America, which reported $2,243,214.01 across 77 transactions to 69 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $29.1K per transaction and $32.5K per recipient.

The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Travel and Lodging" at $8.4K, accounting for 0.4% of the company's reported total and 24 transactions.

General Payment Breakdown by Type

"Travel and Lodging" leads Orchard Therapeutics North America's 3-category general-payment breakdown at $8.4K, 0.4% of the reported total.

How Orchard Therapeutics North America divides its payments

Ranked by total dollars reported per category

1. Travel and Lodging$8.4K2. Consulting Fee$3.0K3. Food and Beverage$2.6K
Payment Type Amount Transactions
Travel and Lodging $8.4K 24
Consulting Fee $3.0K 1
Food and Beverage $2.6K 44

Recipient Concentration in General Payments

The five largest recipient relationships account for $12,325.83 (87.7%) of $14,046.59 in this company's General Payments records across 17 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Orchard Therapeutics North America

The five named recipients with the highest reported General Payments from this company

Laura Adang$4.0KLouis Cohen$3.0KJennifer Braun$2.4KLisa Tennyson Emrick$1.7KSuhag Parikh$1.2K
  1. 1

    Laura Adang

    $4,018.76 across 18 reported transactions

  2. 2

    Louis Cohen

    $3,040.00 across 1 reported transactions

  3. 3

    Jennifer Braun

    $2,359.10 across 14 reported transactions

  4. 4

    Lisa Tennyson Emrick

    $1,746.40 across 8 reported transactions

  5. 5

    Suhag Parikh

    $1,161.57 across 8 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $29.1K. Average per recipient: $32.5K.

Total Amount

$2,243,214.01

Avg per Transaction

$29.1K

Avg per Recipient

$32.5K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Orchard Therapeutics North America Share

0.0%

#425 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Orchard Therapeutics North America

Fujirebio Diagnostics, Incorporated

$2.2M 10 recipients

New World Medical,inc.

$2.2M 3,180 recipients

Ceribell, Inc.

$2.3M 1,173 recipients

Smarter Devices, LLC

$2.2M 0 recipients

United Imaging Healthcare North America, Inc.

$2.2M 66 recipients

Aimmune Therapeutics, Inc.

$2.3M 32,592 recipients

Frequently Asked Questions

How much did Orchard Therapeutics North America pay to physicians and hospitals in 2024? ▾
Orchard Therapeutics North America made $2,243,214.01 in payments to physicians and hospitals in Program Year 2024, across 77 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Orchard Therapeutics North America? ▾
69 physicians and teaching hospitals received payments from Orchard Therapeutics North America in 2024, averaging $32.5K per recipient.
What types of payments did Orchard Therapeutics North America make? ▾
General payments from Orchard Therapeutics North America span 3 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Travel and Lodging" at $8.4K, representing 0.4% of the company's reported total.
How does Orchard Therapeutics North America rank among pharmaceutical companies? ▾
By total payment amount, Orchard Therapeutics North America sits at #425 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Orchard Therapeutics North America? ▾
In 2024, Orchard Therapeutics North America averaged $29.1K per transaction across 77 transactions to 69 recipients.
Where does the payment data for Orchard Therapeutics North America come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Orchard Therapeutics North America's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.